The Administrative Core is composed of Cancer Center Administration and Senior Leadership of the Sidney Kimmel Comprehensive Cancer Center (SKCCC). The SKCCC Administration's purposes are to facilitate the overall planning, management and organization of the activities of the SKCCC, and to provide the support necessary to achieve and maintain the highest standards of cancer research excellence at the SKCCC. Administration is vital in assuring that the SKCCC achieves its goals and objectives and complies with NCI guidelines for Cancer Center Support Grants (CCSG). These goals are accomplished through an administrative infrastructure that enables streamlined and effective assistance to the Director, Senior Leaders, Program Leaders, Advisory Groups, Core Directors/Managers and general membership. SKCCC Administration provides the centralized management of resources and services required for the SKCCC's research activities, fiscal management and reporting functions. Coordinated activities include: participation in SKCCC governance and decision-making processes; representation of the SKCCC within the institution; oversight and management of CCSG relevant activities, including planning and evaluation oversight of Cores; faculty recruitment support; and management of the membership process and data, space, budgeting and finances, and the CCSG application. SKCCC Senior Leadership is responsible for overall planning and operational activities, administrative and management functions that support SKCCC research, and all scientific Program functions as described in detail throughout this CCSG application. The overall responsibility for planning and operation of research rests with the Director of the SKCCC, William G. Nelson, M.D., Ph.D. Dr. Nelson has carefully assembled a highly cohesive and dynamic Senior Leadership team with a strong commitment to the goals, values and priorities of the SKCCC. The Deputy Director and Associate Directors (ADs) have broad responsibilities and work with the Director to plan scientific direction with particular emphasis on Program interaction and translational research. The Deputy Director and ADs have significant oversight responsibilities for the Research Programs and in research training, education, community programs and outreach. Their collective success is evidenced by new strategic initiatives, evolution of Programs, development of Cores, increased transdisciplinary collaboration along the translational pipeline and, in particular, the impact on the SKCCC catchment area. They are continuously focused on the priorities of the SKCCC, including understanding and addressing cancer disparities. SKCCC leadership includes the Director, Deputy Director (Elizabeth M. Jaffee, M.D.), an AD for Clinical Research (Michael A. Carducci, M.D.), an AD for Population Sciences (John D. Groopman, Ph.D.), an AD for Shared Resources (Robert A. Casero, Ph.D.), an AD for Laboratory Research (Kenneth Kinzler, Ph.D.), an AD for Research Training and Education (Ben Park, M.D., Ph.D.), and an AD for Administration (Rosalie W ollett).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
United States
Zip Code
Kaur, Harsimar B; Guedes, Liana B; Lu, Jiayun et al. (2018) Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer. Mod Pathol 31:1539-1552
Connolly, Roisin M; Fackler, Mary Jo; Zhang, Zhe et al. (2018) Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Res Treat 167:107-116
Ye, I Chae; Fertig, Elana J; DiGiacomo, Josh W et al. (2018) Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes. Mol Cancer Res 16:1889-1901
Zhu, Yezi; Sharp, Adam; Anderson, Courtney M et al. (2018) Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. Eur Urol 73:727-735
Lu, Yunqi; Hu, Zhongyi; Mangala, Lingegowda S et al. (2018) MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. Cancer Res 78:64-74
Rao, Karthik; Liang, Stella; Cardamone, Michael et al. (2018) Cost implications of PSA screening differ by age. BMC Urol 18:38
Johnson, Renee M; Fleming, Charles B; Cambron, Christopher et al. (2018) Race/Ethnicity Differences in Trends of Marijuana, Cigarette, and Alcohol Use Among 8th, 10th, and 12th Graders in Washington State, 2004-2016. Prev Sci :
Marrone, Kristen A; Zhou, Xian; Forde, Patrick M et al. (2018) A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. Oncologist 23:859-865
Bar-Shir, Amnon; Alon, Lina; Korrer, Michael J et al. (2018) Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy. Magn Reson Med 79:1010-1019
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521

Showing the most recent 10 out of 2393 publications